Logo image of DCBO

DOCEBO INC (DCBO) Stock Fundamental Analysis

USA - NASDAQ:DCBO - CA25609L1058 - Common Stock

27.6 USD
+0.16 (+0.58%)
Last: 10/6/2025, 9:36:22 PM
Fundamental Rating

6

Taking everything into account, DCBO scores 6 out of 10 in our fundamental rating. DCBO was compared to 281 industry peers in the Software industry. DCBO has an excellent financial health rating, but there are some minor concerns on its profitability. DCBO is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make DCBO suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

DCBO had positive earnings in the past year.
In the past year DCBO had a positive cash flow from operations.
In multiple years DCBO reported negative net income over the last 5 years.
DCBO had a positive operating cash flow in 4 of the past 5 years.
DCBO Yearly Net Income VS EBIT VS OCF VS FCFDCBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

DCBO has a Return On Assets of 12.51%. This is amongst the best in the industry. DCBO outperforms 89.32% of its industry peers.
With an excellent Return On Equity value of 61.75%, DCBO belongs to the best of the industry, outperforming 96.80% of the companies in the same industry.
DCBO has a better Return On Invested Capital (32.53%) than 97.15% of its industry peers.
Industry RankSector Rank
ROA 12.51%
ROE 61.75%
ROIC 32.53%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO Yearly ROA, ROE, ROICDCBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

DCBO's Profit Margin of 9.29% is fine compared to the rest of the industry. DCBO outperforms 72.60% of its industry peers.
DCBO's Operating Margin of 9.67% is fine compared to the rest of the industry. DCBO outperforms 74.02% of its industry peers.
Looking at the Gross Margin, with a value of 81.00%, DCBO belongs to the top of the industry, outperforming 83.63% of the companies in the same industry.
In the last couple of years the Gross Margin of DCBO has remained more or less at the same level.
Industry RankSector Rank
OM 9.67%
PM (TTM) 9.29%
GM 81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO Yearly Profit, Operating, Gross MarginsDCBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DCBO is creating value.
DCBO has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for DCBO has been increased compared to 5 years ago.
Compared to 1 year ago, DCBO has an improved debt to assets ratio.
DCBO Yearly Shares OutstandingDCBO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO Yearly Total Debt VS Total AssetsDCBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 3.50 indicates that DCBO is not in any danger for bankruptcy at the moment.
DCBO has a better Altman-Z score (3.50) than 61.92% of its industry peers.
The Debt to FCF ratio of DCBO is 0.05, which is an excellent value as it means it would take DCBO, only 0.05 years of fcf income to pay off all of its debts.
DCBO has a Debt to FCF ratio of 0.05. This is amongst the best in the industry. DCBO outperforms 82.56% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that DCBO is not too dependend on debt financing.
DCBO has a Debt to Equity ratio of 0.01. This is in the better half of the industry: DCBO outperforms 64.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Altman-Z 3.5
ROIC/WACC3.09
WACC10.54%
DCBO Yearly LT Debt VS Equity VS FCFDCBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

DCBO has a Current Ratio of 1.04. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
DCBO has a worse Current ratio (1.04) than 70.11% of its industry peers.
DCBO has a Quick Ratio of 1.04. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
DCBO's Quick ratio of 1.04 is on the low side compared to the rest of the industry. DCBO is outperformed by 69.39% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
DCBO Yearly Current Assets VS Current LiabilitesDCBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.70% over the past year.
Looking at the last year, DCBO shows a quite strong growth in Revenue. The Revenue has grown by 15.11% in the last year.
DCBO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.25% yearly.
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%14.47%

3.2 Future

The Earnings Per Share is expected to grow by 27.76% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 24.94% on average over the next years. This is a very strong growth
EPS Next Y37.82%
EPS Next 2Y33.47%
EPS Next 3Y34.47%
EPS Next 5Y27.76%
Revenue Next Year11.22%
Revenue Next 2Y9.78%
Revenue Next 3Y9.84%
Revenue Next 5Y24.94%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DCBO Yearly Revenue VS EstimatesDCBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO Yearly EPS VS EstimatesDCBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 25.09 indicates a quite expensive valuation of DCBO.
Compared to the rest of the industry, the Price/Earnings ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 71.89% of the companies listed in the same industry.
DCBO is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.90, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 18.02, the valuation of DCBO can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 78.65% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.36. DCBO is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 25.09
Fwd PE 18.02
DCBO Price Earnings VS Forward Price EarningsDCBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DCBO is valued a bit cheaper than 75.80% of the companies in the same industry.
DCBO's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 71.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.47
EV/EBITDA 28.43
DCBO Per share dataDCBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

DCBO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DCBO has a very decent profitability rating, which may justify a higher PE ratio.
DCBO's earnings are expected to grow with 34.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.66
PEG (5Y)N/A
EPS Next 2Y33.47%
EPS Next 3Y34.47%

0

5. Dividend

5.1 Amount

No dividends for DCBO!.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

NASDAQ:DCBO (10/6/2025, 9:36:22 PM)

27.6

+0.16 (+0.58%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners31.4%
Inst Owner Change0%
Ins Owners1.51%
Ins Owner ChangeN/A
Market Cap792.95M
Analysts78.67
Price Target29.69 (7.57%)
Short Float %2.2%
Short Ratio3.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.06%
Min EPS beat(2)26.05%
Max EPS beat(2)28.07%
EPS beat(4)3
Avg EPS beat(4)41.65%
Min EPS beat(4)-25.3%
Max EPS beat(4)137.79%
EPS beat(8)7
Avg EPS beat(8)31.82%
EPS beat(12)10
Avg EPS beat(12)131.11%
EPS beat(16)13
Avg EPS beat(16)110.84%
Revenue beat(2)1
Avg Revenue beat(2)-0.14%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)1.34%
Revenue beat(4)2
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.44%
Revenue beat(12)2
Avg Revenue beat(12)-0.71%
Revenue beat(16)3
Avg Revenue beat(16)-0.87%
PT rev (1m)-0.46%
PT rev (3m)1.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.52%
EPS NY rev (1m)1.75%
EPS NY rev (3m)-1.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.48%
Valuation
Industry RankSector Rank
PE 25.09
Fwd PE 18.02
P/S 3.44
P/FCF 29.47
P/OCF 28.07
P/B 22.86
P/tB 42.17
EV/EBITDA 28.43
EPS(TTM)1.1
EY3.99%
EPS(NY)1.53
Fwd EY5.55%
FCF(TTM)0.94
FCFY3.39%
OCF(TTM)0.98
OCFY3.56%
SpS8.02
BVpS1.21
TBVpS0.65
PEG (NY)0.66
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.51%
ROE 61.75%
ROCE 55.51%
ROIC 32.53%
ROICexc N/A
ROICexgc N/A
OM 9.67%
PM (TTM) 9.29%
GM 81%
FCFM 11.67%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score8
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Debt/EBITDA 0.01
Cap/Depr 39.68%
Cap/Sales 0.58%
Interest Coverage 250
Cash Conversion 110.06%
Profit Quality 125.62%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 3.5
F-Score8
WACC10.54%
ROIC/WACC3.09
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
EPS Next Y37.82%
EPS Next 2Y33.47%
EPS Next 3Y34.47%
EPS Next 5Y27.76%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%14.47%
Revenue Next Year11.22%
Revenue Next 2Y9.78%
Revenue Next 3Y9.84%
Revenue Next 5Y24.94%
EBIT growth 1Y84.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year125.27%
EBIT Next 3Y50.67%
EBIT Next 5Y32.58%
FCF growth 1Y380.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y338.61%
OCF growth 3YN/A
OCF growth 5YN/A